Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist

RHO5:GR

251.930 EUR 0.310 0.12%

As of 12:36:04 ET on 03/27/2015.

Snapshot for Roche Holding AG (RHO5)

Open: 251.750 Day's Range: 250.000 - 255.394 Volume: 10,713
Previous Close: 251.620 52wk Range: 203.700 - 261.800 1-Yr Rtn: +19.01%

Stock Chart for RHO5

No chart data available.
  • RHO5:GR 251.930
  • 1D
  • 1M
  • 1Y
251.620
Interactive RHO5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHO5

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 18.9161
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2015) 13.9490
Est. PEG Ratio 3.5543
Market Cap (M EUR) 216,336.83
Shares Outstanding (M) 702.56
30 Day Average Volume 16,526
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.96%
Cash Dividend (CHF) 8.0000
Dividend Ex-Date 03/05/2015
5 Year Dividend Growth 12.70%
Next Earnings Announcement 07/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHO5

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RHO5

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for RHO5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil